Financial News

Recent Quotes
My Watchlist
Indicators
Markets
Stocks
Funds
Tools
Overview
News
Currencies
International
Treasuries

Arena Pharmaceuticals (NQ: ARNA )

65.90 USD -2.09 (-3.07%)
Official Closing Price Updated: 4:59 PM EDT, Apr 16, 2021 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Stories about Arena Pharmaceuticals

< Previous 1 2 3 4 5 6 7 8 9 10 Next >
My Top 3 Favorite Clinical-Stage Biotech Stocks to Buy
These biotech upstarts have deep pockets and late-stage pipelines that could make them savvy buys. 
Tags UTHR REGN BLUE
From Motley Fool
ARNA February 2019 Options Begin Trading
Investors in Arena Pharmaceuticals Inc (ARNA) saw new options become available today, for the February 2019 expiration. One of the key inputs that goes into the price an option buyer is willing to pay,... 
Tags Stocks
From Market News Video
11 NYSE- And NASDAQ-Listed Stocks With Cannabis Exposure
For investors who are seeking exposure to the cannabis industry but consider pure-play companies too risky, there are many other ... 
Tags Top Stories Markets NETE
From Benzinga
64 Biggest Movers From Yesterday
Gainers uniQure N.V. (NASDAQ: QURE) shares jumped 35.66 percent to close at $30.93 on Thursday after the company reported all ... 
Tags Losers CDTI IT Consulting & Other Services
From Benzinga
Cramer's lightning round: This biotech has the perfect stock for this environment
Jim Cramer rattles off his take on callers' favorite stocks, including a biotechnology play ripe for the picking. 
Tags Investing/Stock Market/Stock Picks BP PLC Jim Cramer
From CNBC.com News
Why Arena Pharmaceuticals, Smart & Final Stores, and Tilray Jumped Today
Smart strategic moves helped these stocks gain ground. 
Tags SFS TLRY Market News
From Motley Fool
Noteworthy Thursday Option Activity: RESI, CRMT, ARNA
Among the underlying components of the Russell 3000 index, we saw noteworthy options trading volume today in Front Yard Residential Corp (RESI), where a total of 6,915 contracts have traded so far,... 
Tags Stocks
From Market News Video
45 Stocks Moving In Thursday's Mid-Day Session
Gainers Sonoma Pharmaceuticals, Inc. (NASDAQ: SNOA) shares rose 48.6 percent to $1.58. uniQure N.V. (NASDAQ: QURE) shares ... 
Tags AKER NVCN NTES
From Benzinga
This Biotech Stock Is Flying On A $1.2 Billion Licensing Deal
Arena Pharmaceuticals rocketed in bullish fashion Thursday after announcing a $1.2 billion licensing deal with United Therapeutics for an arterial disease treatment. 
From Investor's Business Daily
Mid-Day Market Update: Smart & Final Stores Rises Following Strong Q3 Earnings; Remark Holdings Shares Drop
Midway through trading Thursday, the Dow traded down 0.44 percent to 24,969.12 while the NASDAQ climbed 0.25 percent to 7,154.28. The ... 
Tags SWCH ARNA Commodities
From Benzinga
Here's Why Arena Pharmaceuticals Jumped as Much as 30.6% Today
The company moved to immediately monetize a promising drug candidate. For a cool $800 million up-front payment, investors can't complain. 
Tags ARNA UTHR Market News
From Motley Fool
Mid-Morning Market Update: Markets Open Lower; Walmart Profit Tops Expectations
Following the market opening Thursday, the Dow traded down 0.57 percent to 24,938.48 while the NASDAQ declined 0.22 percent to 7,120.69. ... 
Tags News SFS Benzinga
From Benzinga
34 Stocks Moving In Thursday's Pre-Market Session
Gainers XpresSpa Group Inc (NASDAQ: XSPA) rose 23.4 percent to $0.22 in pre-market trading after the company reported Q3 EPS up ... 
Tags XSPA DSS Market News
From Benzinga
United Therapeutics to develop, sell Arena Pharma's hypertension treatment
United Therapeutics Corp on Thursday signed a deal potentially worth up to $1.2 billion for the rights to develop and sell Arena Pharmaceuticals Inc's pulmonary arterial hypertension treatment,... 
Tags companyNews
From Reuters: Company News
34 Stocks Moving In Friday's Pre-Market Session
Gainers Finisar Corporation (NASDAQ: FNSR) shares rose 28 percent to $24.17 in pre-market trading after II-VI announced plans to ... 
Tags MOMO YELP Market News
From Benzinga
Arena Pharmaceuticals Shows Market Leadership With Jump To 83 RS Rating
Arena Pharmaceuticals shows improving price performance, earning an upgrade to its IBD Relative Strength Rating from 80 to 83. 
From Investor's Business Daily
The Daily Biotech Pulse: FDA Nod For Bristol-Myers Squibb, Momenta Strikes Patent License Deal With AbbVie
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peak (Biotech stocks hitting ... 
Tags IBB TCON PDLI
From Benzinga
Cramer's lightning round: This stock could recover if the Democrats win the House
Jim Cramer says a biotechnology stock could launch a recovery if the midterm elections bring a blue wave to Congress. 
Tags Activision Blizzard Inc Personal investing Take/Two Interactive Software Inc
From CNBC.com News
Arena Pharmaceuticals Meets 80-Plus Relative Strength Rating Benchmark
Arena Pharmaceuticals shows rising price performance, earning an upgrade to its IBD Relative Strength Rating from 76 to 81. 
From Investor's Business Daily
The Week Ahead In Biotech: Earnings, Conferences, PDUFA Dates, Clinical Trial Results And IPOs
Biotech earnings news flow accelerated in last week, with Pfizer Inc. (NYSE: PFE) and Sanofi SA (NYSE: SNY) among the noteworthy ... 
Tags ONVO KIN CRVS
From Benzinga
Interesting ARNA Put And Call Options For December 14th
Investors in Arena Pharmaceuticals Inc (ARNA) saw new options begin trading today, for the December 14th expiration. At Stock Options Channel, our YieldBoost formula has looked up and down the ARNA... 
Tags Stocks
From Market News Video
Analysts Anticipate FYC To Hit $55
Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, we have compared the trading price of each holding against the average analyst 12-month forward target price, and... 
Tags ETFs
From ETF Channel
Arena Pharmaceuticals Hits 80-Plus Relative Strength Rating Benchmark
Arena Pharmaceuticals sees its Relative Strength Rating enter the 80-plus level. 
From Investor's Business Daily
Stock Upgrades: Arena Pharmaceuticals Shows Rising Relative Strength
Arena Pharmaceuticals shows improving price performance, earning an upgrade to its IBD Relative Strength Rating from 80 to 87. 
From Investor's Business Daily
The Daily Biotech Pulse: Affimed's Cancer Drug Placed On Clinical Hold, Celgene's Positive Scalp Psoriasis Trial
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling the Peaks (Biotech stocks hitting ... 
Tags ALNY FDA LJPC
From Benzinga
Notable Friday Option Activity: WGO, ARNA, RMBS
Looking at options trading activity among components of the Russell 3000 index, there is noteworthy activity today in Winnebago Industries, Inc. (WGO), where a total volume of 3,081 contracts has been... 
Tags Stocks
From Market News Video
Analysts Predict 10% Upside For The Holdings of FYX
Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, we have compared the trading price of each holding against the average analyst 12-month forward target price, and... 
Tags ETFs
From ETF Channel
Biotech Rises On Crohn's Disease Study For Cannabinoid Drug
Arena Pharmaceuticals jumped early Tuesday on promising data for its non-opioid treatment for Crohn's disease pain. 
From Investor's Business Daily
Morning Call For Tuesday, Sept. 25
Dec E-mini S&Ps (ESZ18 +0.18%) this morning are up +0.26% and European stocks are up +0.33% as strength in energy stocks leads the overall market higher. 
Tags Stocks / Equities Currencies/Forex Commodities
From Blogs - TalkMarkets
The Daily Biotech Pulse: Syndax Lung Cancer Trial Disappoints, Gemphire To Trim Workforce, Opiant's Offering
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling the Peaks (Biotech stocks hitting ... 
Tags MDT RLM News
From Benzinga
< Previous 1 2 3 4 5 6 7 8 9 10 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.

Use the myMotherLode.com Keyword Search to go straight to a specific page

Popular Pages

  • Local News
  • US News
  • Weather
  • State News
  • Events
  • Traffic
  • Sports
  • Dining Guide
  • Real Estate
  • Classifieds
  • Financial News
  • Fire Info
Terms of Service Privacy Policy
© Copyright 2000-2019 Clarke Broadcasting Corporation. All rights reserved.
Feedback